IL‐2mAb treatment attenuated both MBP loss and SMI‐32 increase in the ischemic cortex and protected the integrity of the lateral corpus callosum at 7 days after stroke in dMCAO model (Figure 3B). This evidence concerns the gene MBP and Stroke.